DiaGenic ASA Reports High 85% Accuracy for Blood Based Diagnosis in Early Parkinson Patients in European Multicenter Study  
2/8/2012 9:41:40 AM

OSLO, Norway--(BUSINESS WIRE)--Regulatory News:

The initial findings from DiaGenic (OSE:DIAG) sponsored prospective European multicenter Parkinson study is reported. The initial read out of the first subcohort of 79 PD patients and 75 matched healthy controls with no neurodegenerative disease, shows a diagnostic accuracy of 85% in early disease patients while overall accuracy was 88% across all stages.